A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)

NCT04530994 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Alagille Syndrome

Interventions

DRUG: maralixibat

Sponsor

Mirum Pharmaceuticals, Inc.

Collaborators

[object Object]